SUSQUEHANNA INTERNATIONAL GROUP, LLP - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 79 filers reported holding HUMACYTE INC in Q2 2022. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$287,237
+85.1%
98,033
+80.6%
0.00%
Q2 2023$155,206
+60.1%
54,268
+73.0%
0.00%
Q1 2023$96,924
+70.2%
31,367
+16.2%
0.00%
Q4 2022$56,959
-91.7%
26,995
-87.2%
0.00%
Q3 2022$688,000
-15.4%
210,955
-16.7%
0.00%
Q2 2022$813,000
-70.2%
253,202
-34.5%
0.00%
Q1 2022$2,729,000
-20.3%
386,500
-18.2%
0.00%
Q4 2021$3,426,000
-40.5%
472,600
-4.8%
0.00%
-100.0%
Q3 2021$5,762,000496,3000.00%
Other shareholders
HUMACYTE INC shareholders Q2 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
View complete list of HUMACYTE INC shareholders